Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Journal of Hepatocellular Carcinoma
Volume Volume 10, Issue -, Pages 1955-1971
Publisher
Informa UK Limited
Online
2023-11-03
DOI
10.2147/jhc.s291553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.
- (2023) Yao Liu et al. JOURNAL OF HEPATOLOGY
- Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
- (2023) Shovan Dutta et al. Biology-Basel
- Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trial
- (2023) Philippe Merle et al. DIGESTIVE AND LIVER DISEASE
- Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
- (2023) Daniela Gabbia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma
- (2023) Masahiro Morita et al. Cancers
- The promise and challenge of spatial omics in dissecting tumour microenvironment and the role of AI
- (2023) Ren Yuan Lee et al. Frontiers in Oncology
- Current status and prospect of treatments for recurrent hepatocellular carcinoma
- (2023) Yu-Qing Yang et al. World Journal of Hepatology
- Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials
- (2023) Claudia Angela Maria Fulgenzi et al. JHEP Reports
- Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma
- (2023) David J. Pinato et al. JHEP Reports
- Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
- (2022) Carla Montironi et al. GUT
- Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
- (2022) David Repáraz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
- (2022) Cheng-Long Han et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cancer vaccines as promising immuno-therapeutics: platforms and current progress
- (2022) Jian Liu et al. Journal of Hematology & Oncology
- T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma
- (2022) Maryam Barsch et al. JOURNAL OF HEPATOLOGY
- Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters
- (2022) Alessio Cortellini et al. Journal of Thoracic Oncology
- Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
- (2022) Darren Jun Hao Tan et al. LANCET ONCOLOGY
- Cancer associated fibroblast–derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axis
- (2022) Haixu Xu et al. Cell Death & Disease
- Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial
- (2022) Robin Kate Kelley et al. LANCET ONCOLOGY
- The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma
- (2022) Nanni Hua et al. MOLECULAR BIOLOGY REPORTS
- CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives
- (2022) Semira Sheikh et al. Biomedicines
- Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
- (2022) Claudia Angela Maria Fulgenzi et al. EUROPEAN JOURNAL OF CANCER
- Cancer Resistance to Immunotherapy: Molecular Mechanisms and Tackling Strategies
- (2022) Son Hai Vu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global burden of primary liver cancer in 2020 and predictions to 2040
- (2022) Harriet Rumgay et al. JOURNAL OF HEPATOLOGY
- Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma
- (2022) Chan Kim et al. JAMA Oncology
- Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
- (2022) Hai Feng et al. Journal of Hepatocellular Carcinoma
- Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial
- (2022) Thomas Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy impairment as a key feature for acetaminophen-induced ototoxicity
- (2021) Tong Zhao et al. Cell Death & Disease
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
- (2021) Xingxing Gao et al. Frontiers in Oncology
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
- (2021) Alessio Cortellini et al. Journal for ImmunoTherapy of Cancer
- TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma
- (2021) Zhouhong Ge et al. Cellular and Molecular Gastroenterology and Hepatology
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
- (2021) Alexander Bagaev et al. CANCER CELL
- Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny
- (2021) Jianpeng Sheng et al. GUT
- Epithelial–Mesenchymal Transition (EMT) Induced by TGF-β in Hepatocellular Carcinoma Cells Reprograms Lipid Metabolism
- (2021) Jitka Soukupova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer
- (2021) Abdul Rafeh Naqash et al. Annals of Translational Medicine
- Epigenetic mechanisms of liver tumor resistance to immunotherapy
- (2021) Julie Sanceau et al. World Journal of Hepatology
- Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma
- (2021) Mary Wong et al. Hepatic Oncology
- Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
- (2021) Alessandro Vitale et al. GUT
- Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
- (2021) Ann-Lii Cheng et al. JOURNAL OF HEPATOLOGY
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial
- (2021) Thomas Yau et al. LANCET ONCOLOGY
- Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
- (2021) Xiaoqi Mao et al. Molecular Cancer
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- p53, cancer and the immune response
- (2020) Julianna Blagih et al. JOURNAL OF CELL SCIENCE
- Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses
- (2020) Julianna Blagih et al. Cell Reports
- Calreticulin Blockade Attenuates Murine Acute Lung Injury by Inducing Polarization of M2 Subtype Macrophages
- (2020) Zhilong Jiang et al. Frontiers in Immunology
- Immune checkpoint signaling and cancer immunotherapy
- (2020) Xing He et al. CELL RESEARCH
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-based therapies for hepatocellular carcinoma
- (2020) David J. Pinato et al. ONCOGENE
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
- (2020) Patrick A. Ott et al. CELL
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib
- (2020) Thomas Yau et al. JAMA Oncology
- LAG-3: from molecular functions to clinical applications
- (2020) Takumi Maruhashi et al. Journal for ImmunoTherapy of Cancer
- Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
- (2020) Sreya Bagchi et al. Annual Review of Pathology-Mechanisms of Disease
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Blocking TREM-1+ Tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-PD-L1 resistance in liver cancer
- (2019) Qinchuan Wu et al. HEPATOLOGY
- PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling
- (2019) Zhongyi Fan et al. CANCER LETTERS
- The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
- (2019) Jacopo Baglieri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
- (2019) Jasmine Davda et al. Journal for ImmunoTherapy of Cancer
- TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
- (2019) Omar Khan et al. NATURE
- Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
- (2019) Jian Chen et al. TRENDS IN MOLECULAR MEDICINE
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer
- (2019) David J. Pinato et al. JAMA Oncology
- Anti-drug Antibodies Against Immune Checkpoint Blockers: Impairment of drug efficacy or indication of immune activation?
- (2019) Diego Enrico et al. CLINICAL CANCER RESEARCH
- Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling
- (2019) Ching-Chuan Hsieh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- (2019) Jiaqiang Ma et al. Journal for ImmunoTherapy of Cancer
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
- (2018) Linda Ziani et al. Frontiers in Immunology
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next Generation Sequencing for Matching Patients to Targeted and Immune Therapies
- (2018) James J Harding et al. CLINICAL CANCER RESEARCH
- The innate immune receptor TREM-1 promotes liver injury and fibrosis
- (2018) Anh Thu Nguyen-Lefebvre et al. JOURNAL OF CLINICAL INVESTIGATION
- Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis
- (2018) Nicholas A. Scott et al. Science Translational Medicine
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- LAG3 (CD223) as a cancer immunotherapy target
- (2017) Lawrence P. Andrews et al. IMMUNOLOGICAL REVIEWS
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
- (2017) Scott Gettinger et al. Cancer Discovery
- Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma
- (2017) Zhi-Zhang Yang et al. Oncotarget
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Carcinoma-associated fibroblasts: orchestrating the composition of malignancy
- (2016) Philippe Gascard et al. GENES & DEVELOPMENT
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
- (2016) Y Deng et al. ONCOGENE
- Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
- (2016) Emilie M.J. van Brummelen et al. ONCOLOGIST
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
- (2016) Yukihiro Haruyama WORLD JOURNAL OF GASTROENTEROLOGY
- TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
- (2016) Daniel Zysset et al. Nature Communications
- TGF 1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
- (2016) B. V. Park et al. Cancer Discovery
- Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
- (2016) J-t Cheng et al. Oncogenesis
- LAG3 Expression in Active Mycobacterium tuberculosis Infections
- (2015) Bonnie L. Phillips et al. AMERICAN JOURNAL OF PATHOLOGY
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma
- (2015) Jiang Chen et al. CANCER LETTERS
- Proton pump inhibitors alter the composition of the gut microbiota
- (2015) Matthew A Jackson et al. GUT
- Using Corticosteroids to Reshape the Gut Microbiome
- (2015) Edmond Y. Huang et al. INFLAMMATORY BOWEL DISEASES
- The Upregulation of LAG-3 on T Cells Defines a Subpopulation with Functional Exhaustion and Correlates with Disease Progression in HIV-Infected Subjects
- (2015) Xiaoling Tian et al. JOURNAL OF IMMUNOLOGY
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
- (2015) D. S. Thommen et al. Cancer Immunology Research
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- The Impact of Proton Pump Inhibitors on the Human Gastrointestinal Microbiome
- (2014) Daniel E. Freedberg et al. CLINICS IN LABORATORY MEDICINE
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of the anti-tumour immune response by cancer-associated fibroblasts
- (2014) James Harper et al. SEMINARS IN CANCER BIOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Hepatic stellate cells in liver development, regeneration, and cancer
- (2013) Chunyue Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
- (2013) Bastian Höchst et al. JOURNAL OF HEPATOLOGY
- Hepatic Stellate Cells Preferentially Induce Foxp3+ Regulatory T Cells by Production of Retinoic Acid
- (2013) R. M. Dunham et al. JOURNAL OF IMMUNOLOGY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Correction: Global Conformational Selection and Local Induced Fit for the Recognition between Intrinsic Disordered p53 and CBP
- (2013) Qingfen Yu et al. PLoS One
- The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma
- (2012) Juan Wu et al. CANCER RESEARCH
- Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma
- (2012) Rui Liao et al. CANCER SCIENCE
- Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients
- (2012) Fu-Jun Li et al. IMMUNOLOGY LETTERS
- Levels of Plasma-soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Are Correlated with Disease Activity in Rheumatoid Arthritis
- (2012) S. T. CHOI et al. JOURNAL OF RHEUMATOLOGY
- Vstm3 is a member of the CD28 family and an important modulator of T-cell function
- (2011) Steven D. Levin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
- (2011) Taku Okazaki et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
- (2011) Noah S Butler et al. NATURE IMMUNOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
- (2010) P Neeson et al. GENE THERAPY
- Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome
- (2010) Hedvig E. Jakobsson et al. PLoS One
- Tumor-infiltrating NY-ESO-1–specific CD8+T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
- (2010) Junko Matsuzaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
- (2010) Ju Dong Yang et al. SEMINARS IN CANCER BIOLOGY
- Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
- (2009) Y. Hoshida et al. CANCER RESEARCH
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
- (2009) Giuseppe Cabibbo et al. HEPATOLOGY
- Reciprocal Interactions between Commensal Bacteria and Intraepithelial Lymphocytes during Mucosal Injury
- (2009) A. S. Ismail et al. JOURNAL OF IMMUNOLOGY
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dysregulation of apoptosis in hepatocellular carcinoma cells
- (2009) Isabel Fabregat WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
- The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
- (2008) Xin Yu et al. NATURE IMMUNOLOGY
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
- TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer
- (2007) Chao-Chi Ho et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More